Selectis Health (GBCS) Shares Outstanding (Weighted Average) (2010 - 2025)

Selectis Health has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $3.1 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $3.1 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (changed 0.0% YoY), and the FY2025 annual result was $3.1 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $3.1 million for Q4 2025 at Selectis Health, roughly flat from $3.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $3.1 million in Q1 2024 to a low of $2.7 million in Q1 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $3.1 million (2023), against an average of $3.0 million.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 90.21% in 2021 and advanced 13.63% in 2022, its largest moves.
• Selectis Health's Shares Outstanding (Weighted Average) stood at $2.8 million in 2021, then climbed by 10.33% to $3.1 million in 2022, then gained by 0.02% to $3.1 million in 2023, then advanced by 0.41% to $3.1 million in 2024, then changed by 0.0% to $3.1 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.1 million (Q4 2025), $3.1 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.